AbbVie/J&J Withdrawal Of Imbruvica Indications Clears Space For Competitors

 
• By Alaric DeArment
  
AbbVie and J&J said they would withdraw two of Imbruvica's lymphoma indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas